Evidence Library

Filter by drug, type, year, and open access.

Drug

Type

Year ≥

Sort

Open access

Active filters:Drug: deutetrabenazine ×Clear filters

Showing 1–2 of 2 results

Effect of potent CYP2D6 inhibition on deutetrabenazine pharmacokinetics — European Journal of Clinical Pharmacology (2021)• Drug: deutetrabenazineDOI
Deutetrabenazine for tardive dyskinesia (AIM-TD phase 3 trial) — The Lancet Psychiatry (2017)• Drug: deutetrabenazineDOI

PsychMed Evidence Library — Guidelines, Trials, Meta-Analyses